Company profile for Intra-Cellular Therapies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Intra-Cellular Therapies is a biopharmaceutical company founded on the late Paul Greengard’s Nobel-prize winning research that uncovered how therapies affect the inner-working of cells in the body. Our mission is to leverage this intracellular approach to deliver treatments that will be transformative for people living with complex psychiatric and neurologic diseases. We celebrate science, welcome curiosity, expect collabora...
Intra-Cellular Therapies is a biopharmaceutical company founded on the late Paul Greengard’s Nobel-prize winning research that uncovered how therapies affect the inner-working of cells in the body. Our mission is to leverage this intracellular approach to deliver treatments that will be transformative for people living with complex psychiatric and neurologic diseases. We celebrate science, welcome curiosity, expect collaboration, and demand integrity and respect in all we do, create and deliver.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
430 East 29th Street Suite 900 New York, NY 10016
Telephone
Telephone
+1 (646) 440-9333
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/marketing/abbvies-skyrizi-and-rinvoq-still-top-tv-drug-ad-spending-stayed-steady-august

FIERCE PHARMA
05 Sep 2025

https://www.businesswire.com/news/home/20250401997629/en/Johnson-Johnson-Announces-Expected-Closing-Date-for-Intra-Cellular-Acquisition

BUSINESSWIRE
01 Apr 2025

https://www.globenewswire.com/news-release/2025/02/21/3030430/30597/en/Intra-Cellular-Therapies-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html

GLOBENEWSWIRE
21 Feb 2025

https://www.reuters.com/markets/deals/jj-buy-intra-cellular-therapies-146-billion-2025-01-13/

REUTERS
14 Jan 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/jj-explores-bid-intra-cellular-therapies-bloomberg-news-reports-2025-01-12/

REUTERS
13 Jan 2025

https://www.globenewswire.com/news-release/2025/01/10/3007508/30597/en/Intra-Cellular-Therapies-Settles-CAPLYTA-lumateperone-Patent-Litigation-with-Sandoz.html

GLOBENEWSWIRE
10 Jan 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty